Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yue Shentu

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|September 3, 2010
A note on dichotomization of continuous response variable in the presence of contamination and model misspecificationYue Shentu, Minge Xie
Contemporary Clinical Trials|May 25, 2013
Consistency assessment with global and bridging development strategies in emerging marketsGang Li, Josh Chen, Hui Quan, et al.
Statistics in Medicine|August 14, 2020
A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival dataPingye Zhang, Junshui Ma, Xinqun Chen, et al.
Journal of Biopharmaceutical Statistics|November 13, 2023
Covariate-adjusted value-guided subgroup identification via boostingJinchun Zhang, Pingye Zhang, Junshui Ma, et al.
Statistics in Medicine|May 7, 2014
Information-based sample size re-estimation in group sequential design for longitudinal trialsJing Zhou, Adeniyi Adewale, Yue Shentu, et al.
Contemporary Clinical Trials|August 28, 2020
Independent drug action and its statistical implications for development of combination therapiesCong Chen, Fang Liu, Yixin Ren, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Early Clinical Development Planning via Biomarkers, Clinical Endpoints, and Simulation: A Case Study to Optimize for Phase 3 Dose SelectionBret Musser, James Bolognese, Ghassan N Fayad, et al.
Drugs & Aging|June 5, 2015
Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority TrialPaul Hartley, Yue Shentu, Patricia Betz-Schiff, et al.
Pharmaceutical Statistics|February 24, 2021
Principal stratum strategy: Potential role in drug developmentBjörn Bornkamp, Kaspar Rufibach, Jianchang Lin, et al.
Statistical Methods in Medical Research|August 29, 2025
A Bayesian approach towards the identification of latent subgroupsEthan M Alt, Peter Yi Guan, Larry Leon, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|September 3, 2010
A note on dichotomization of continuous response variable in the presence of contamination and model misspecificationYue Shentu, Minge Xie
Contemporary Clinical Trials|May 25, 2013
Consistency assessment with global and bridging development strategies in emerging marketsGang Li, Josh Chen, Hui Quan, et al.
Statistics in Medicine|August 14, 2020
A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival dataPingye Zhang, Junshui Ma, Xinqun Chen, et al.
Journal of Biopharmaceutical Statistics|November 13, 2023
Covariate-adjusted value-guided subgroup identification via boostingJinchun Zhang, Pingye Zhang, Junshui Ma, et al.
Statistics in Medicine|May 7, 2014
Information-based sample size re-estimation in group sequential design for longitudinal trialsJing Zhou, Adeniyi Adewale, Yue Shentu, et al.
Contemporary Clinical Trials|August 28, 2020
Independent drug action and its statistical implications for development of combination therapiesCong Chen, Fang Liu, Yixin Ren, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Early Clinical Development Planning via Biomarkers, Clinical Endpoints, and Simulation: A Case Study to Optimize for Phase 3 Dose SelectionBret Musser, James Bolognese, Ghassan N Fayad, et al.
Drugs & Aging|June 5, 2015
Efficacy and Tolerability of Sitagliptin Compared with Glimepiride in Elderly Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control: A Randomized, Double-Blind, Non-Inferiority TrialPaul Hartley, Yue Shentu, Patricia Betz-Schiff, et al.
Pharmaceutical Statistics|February 24, 2021
Principal stratum strategy: Potential role in drug developmentBjörn Bornkamp, Kaspar Rufibach, Jianchang Lin, et al.
Statistical Methods in Medical Research|August 29, 2025
A Bayesian approach towards the identification of latent subgroupsEthan M Alt, Peter Yi Guan, Larry Leon, et al.
Pageof 3